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Introduction  and  Objective:  Acromegaly  is  a  rare,  chronic  and  slowly  developing  endocrine  dis-
order caused  by  hypersecretion  of  human  growth  hormone  and  consequently  of  insulin-like
growth factor-1  during  adulthood.  The  present  study  was  conducted  to  assess  mitral  annular
(MA) size  and  function  between  acromegalic  patients  and  age-  and  gender-matched  healthy
controls by  three-dimensional  speckle-tracking  echocardiography  (3D-STE).  It  also  aimed  to
examine whether  activity  of  the  disease  has  any  effect  on  MA  parameters.
Methods:  This  study  included  27  patients  with  acromegaly,  three  of  whom  were  excluded  due
to inferior  image  quality.  The  mean  age  of  the  remaining  24  patients  was  55.7±14.0  years
and seven  were  male.  Complete  two-dimensional  Doppler  echocardiography  and  3D-STE  were
performed  in  all  cases.
Results:  Significantly  increased  end-diastolic  and  end-systolic  MA  diameter  (2.81±0.36  cm  vs.
2.44±0.34 cm  and  2.00±0.32  cm  vs.  1.65±0.37  cm,  respectively),  area  (9.67±2.33  cm2 vs.
7.38±1.93 cm2 and  5.14±1.62  cm2 vs.  3.74±1.19  cm2,  respectively)  and  perimeter  (11.76±1.42
cm vs.  10.27±1.33  cm  and  8.61±1.23  cm  vs.  7.36±1.10  cm,  respectively)  were  demonstrated
mpared  with  control  subjects.  MA  functional  parameters  were  not
red  to  those  of  healthy  individuals.in acromegalic  patients  co
significantly  altered  compa∗ Corresponding author.
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Conclusions:  MA  dilation  could  be  seen  in  acromegaly  regardless  of  its  activity.  Acromegaly  is
not associated  with  MA  functional  impairment.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an







Dimensões  e  função do  anel  mitral  na  acromegalia:  dados  do  estudo  MAGYAR-Path  por
ecocardiografia  tridimensional  de  speckle  tracking
Resumo
Introdução  e  Objectivo:  A  acromegalia  é  uma  doença  endócrina  rara,  crónica  e  de  desen-
volvimento  lento,  causada  pela  hipersecreção  da  hormona  do  crescimento  humano  e,
consequentemente,  do  fator  de  crescimento  semelhante  à  insulina-1  durante  a  idade  adulta.
O presente  estudo  foi  conduzido  para  avaliar  o  tamanho  e  a  função  do  anel  mitral  (MA)  nos
doentes com  acromegalia  e  controles  saudáveis  emparelhados  por  idade  e  sexo,  por  meio  de
ecocardiografia  tridimensional  com  speckle-tracking  (3DSTE).  O  objetivo  foi  também  examinar
se a  atividade  da  doença  tem  algum  efeito  nos  parâmetros  da  MA.
Métodos:  Este  estudo  incluiu  27  pacientes  com  acromegalia,  três  dos  quais  tiveram  de  ser
excluídos devido  à  qualidade  inferior  de  imagem.  A  média  de  idade  dos  24  pacientes  restantes
foi de  55,7  ±  14,0  anos  (7  homens).  Foram  realizados  em  todos  os  casos  uma  ecocardiografia
Doppler  bidimensional  completa  e  um  3DSTE.
Resultados:  Quando  comparados  com  os  controlos,  os  doentes  acromegálicos  apresentaram
diâmetros  diastólico  e  sistólico  finais  significativamente  dilatados  (2,81  ±  0,36  cm  versus  2,44
± 0,34  cm  e  2,00  ±  0,32  cm  versus  1,65  ±  0,37  cm,  respetivamente),  assim  como  a  área  valvular
(9,67 ±  2,33  cm2  versus  7,38  ±  1,93  cm2  e  5,14  ±  1,62  cm2  versus  3,74  ±  1,19  cm2,  respetiva-
mente) e  o  perímetro  (11,76  ±  1,42  cm  versus  10,27  ±  1,33  cm  e  8,61  ±  1,23  cm  versus  7,36
± 1,10  cm,  respetivamente)  Os  parâmetros  funcionais  da  MA  não  estavam  significativamente
alterados  em  comparação  com  indivíduos  saudáveis.
Conclusões:  A  dilatação  do  MA  pode  ser  observada  na  acromegalia,  independentemente  de  sua
atividade. A  acromegalia  não  está  associada  ao  comprometimento  funcional  da  MA.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Este é  um

































bY  three-dimensionAl  speckle-tRacking  echocardiography  in
Pathological  cases  (MAGYAR-Path  Study).  All  patients  gave
their  informed  consent.  The  study  was  approved  by  thentroduction
cromegaly  is  a  rare,  chronic  and  slowly  developing
ndocrine  disorder  caused  by  hypersecretion  of  human
rowth  hormone  (hGH)  and  consequently  of  insulin-like
rowth  factor-1  (IGF-1)  during  adulthood.1 Acromegalic  car-
iomyopathy  is  reported  to  be  one  of  the  most  important
omplications  of  acromegaly  and  cardiovascular  events  may
e  linked  to  these  hormones.2--4 The  saddle-shaped  mitral
nnulus  (MA)  plays  an  important  role  in  the  filling  and  empty-
ng  of  the  left  heart  chambers.  Perturbations  of  MA  geometry
nd  function  can  be  seen  in  a  number  of  diseases,  particu-
arly  in  valvular  disorders  and  atrial  fibrillation.5 However,
ome  non-valvular  disorders  have  also  been  found  to  be  asso-
iated  with  MA  morphological  and  functional  alterations.6--8
he  present  study  was  conducted  to  compare  MA  size
nd  functional  properties  between  acromegalic  patients
nd  age-  and  gender-matched  healthy  controls  by  three-
imensional  speckle-tracking  echocardiography  (3D-STE). h
25ethods
atient  population
he  study  included  27  patients  with  acromegaly,  three  of
hom  were  excluded  due  to  inferior  image  quality.  The
ean  age  of  the  remaining  24  patients  was  55.7±14.0  years
nd  seven  were  male.  Their  results  were  compared  to  38
ealthy  controls  (mean  age:  53.4±4.4  years,  16  male).  For
ll  patients  and  controls,  3D-STE  was  performed  in  addi-
ion  to  routine  two-dimensional  Doppler  echocardiography.
he  diagnosis  of  acromegaly  was  based  on  and  its  activ-
ty  was  defined  in  accordance  with  current  guidelines,  as
etailed  previously.1 All  acromegalic  patients  were  included
n  the  Motion  Analysis  of  the  heart  and  Great  vesselsuman  research  committee  at  the  University  of  Szeged  and
4
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Figure  1  Images  from  the  three-dimensional  full-volume  dataset  showing  the  mitral  annulus  in  a  patient  with  acromegaly  including
apical 4-chamber  (A)  and  4-chamber  (B)  long-axis  views  and  a  cross-sectional  view  at  the  level  of  the  mitral  annulus  (C7)  optimized












































n long-axis  views.  Area:  mitral  annular  area;  Circ:  mitral  annula
entricle, RA:  right  atrium,  RV:  right  ventricle.
ollowed  the  ethical  guidelines  of  the  1975  Declaration  of
elsinki.
wo-dimensional  Doppler  echocardiography
 Toshiba  ArtidaTM echocardiograph  (Toshiba  Medical  Sys-
ems,  Tokyo,  Japan)  with  a  PST-30SBP  phased-array
ransducer  (1-5  MHz)  was  used  to  perform  standard  two-
imensional  (2D)  Doppler  transthoracic  echocardiographic
xaminations  following  recent  guidelines.9 A  qualitative  (0-
)  scale  was  used  to  grade  mitral  regurgitation,  where  0




D-STE  was  performed  with  the  same  Toshiba  ArtidaTM
chocardiograph  (Toshiba  Medical  Systems,  Tokyo,  Japan)
ttached  to  a  PST-25SX  matrix-array  transducer.10 An  api-
al  window  was  used  for  3D-STE  data  acquisition,  in  which
ix  wedge-shaped  subvolumes  were  acquired  during  a  single
reath-hold  in  sinus  rhythm,  from  which  a  full-volume  3D
ataset  was  created  automatically.  Offline  analysis  of  the  3D
atasets  was  carried  out  using  3D  Wall  Motion  Tracking  soft-
are,  version  2.7  (Toshiba  Medical  Systems,  Tokyo,  Japan).
pical  2-chamber  and  4-chamber  views  and  three  short-axis
iews  --  basal  (C7),  midventricular  and  apical  left  ventricular
LV)  levels  --  were  selected  at  end-diastole  by  the  software.
ollowing  optimization  of  imaging  planes  in  apical  4-  and





25rimeter;  Dist:  mitral  annular  diameter;  LA:  left  atrium,  LV:  left
hological  parameters  were  measured  in  the  C7  short-axis
iew.  The  following  morphological  parameters  were  mea-
ured  at  end-diastole  (just  before  mitral  valve  closure)  and
nd-systole  (just  before  mitral  valve  opening)  (Figure  1)6--8:
 MA  diameter  (MAD),  defined  as  the  perpendicular  line
drawn  from  the  peak  of  MA  curvature  to  the  middle  of
the  straight  MA  border  (anteroposterior  diameter);
 MA  area  (MAA)  measured  by  planimetry;
 MA  perimeter  (MAP)  measured  by  planimetry.
Using  the  above  parameters,  the  following  MA  functional
roperties  were  calculated:
 MA  fractional  shortening  (MAFS),  defined  as  ([end-diastolic
MAD−end-systolic  MAD]/end-diastolic  MAD)×100,
 MA  fractional  area  change  (MAFAC),  defined  as
([end-diastolic  MAA−end-systolic  MAA]/end-diastolic
MAA)×100.
tatistical  analysis
ll  data  were  presented  as  number  (percentage)  or  mean  ±
tandard  deviation.  Differences  in  values  were  considered  to
e  statistically  significant  with  p<0.05.  Pearson’s  coefficient
as  used  for  correlation  between  variables.  Bland  and  Alt-
an’s  method  was  used  for  studying  intra-  and  interobserver
greement.  Data  analyses  were  performed  using  RStudio
eam  statistical  software  (RStudio:  Integrated  Development
or  R.  RStudio,  Inc.,  Boston,  MA,  2015).
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Table  1  Clinical,  demographic  and  two-dimensional  echocardiographic  data  in  acromegalic  patients  and  matched  controls.






Clinical  and  demographic  data
Age,  years  53.4±4.4  55.7±14.0  59.8±10.1  51.5±16.5
Male gender,  %  16  (42)  7  (29)  4  (33)  3  (29)
Hypertension,  %  0  (0)  12  (50)  7  (58)  5  (42)
Diabetes, %  0  (0)  3  (13)  3  (25)  0  (0)
Hypercholesterolemia,  %  0  (0)  9  (38)  5  (42)  4  (33)
Laboratory  findings
Serum  hHG,  ng/ml -- 5.0±6.2 5.4±3.8  4.4±8.5
Serum IGF-1,  ng/ml -- 313±200 425±199 179±92b
Serum  IGF-1  index -- 1.34±0.90 1.83±0.90 0.74±0.40b
Therapy
Somatostatin  analogue,  %  0  (0)  8  (33)  4  (33)  4  (33)
Bromocriptine,  %  0  (0)  8  (33)  5  (42)  3  (25)
Pegvisomant,  %  0  (0)  1  (4)  1  (8)  0  (0)
Hypophysectomy,  %  0  (0)  9  (38)  5  (42)  4  (33)
Two-dimensional  echocardiography
LA diameter,  mm  39.0±4.0  42.1±5.6a 41.2±6.4  43.3±4.5a
LVEDD,  mm  48.3±4.1  51.1±5.4a 49.9±5.2  52.8±5.6a
LVEDV,  ml  111.3±36.3  128.3±28.6a 122.6±24.8  136.1±33.1a
LVESD,  mm  32.4±4.6  32.0±5.0  30.6±4.9  33.9±4.7
LVESV, ml  39.4±13.7  42.7±15.7  38.5±14.6  48.4±16.3
IVS, mm  9.2±1.3  10.1±1.5a 10.5±1.8a 9.6±0.9
LV PW,  mm  9.5±1.3  10.9±1.9a 10.9±2.1a 10.9  ±1.8a
LVEF,  %  64.4±3.4  66.7±7.7  68.1±8.7  64.7±6.0
E, cm/s  73.0  ±16.7  62.3±10.4a 57.8±8.2a 68.6±10.2b
A,  cm/s  68.6±17.3  79.3±15.7a 77.7±14.9a 81.4±17.6a
E/A  1.10±0.25  0.81±0.20a 0.76±0.17a 0.88±0.23a
Mean  MR  grade  0.2±0.3  0.7±0.5  0.5±0.5  0.8±0.6
0, % 24  (0)  18  (75)  10  (83)  8  (67)
1, % 0  (0) 5  (21)a 2  (17)  3  (25)a
2,  % 0  (0)  1  (4)  0  (0)  1  (8)
E/A: ratio of early and late diastolic transmitral flow velocity; hGH: human growth hormone; IGF-1: insulin-like growth factor-1; IVS:
interventricular septum; LA: left atrial; LV: left ventricular; LVEDD: end-diastolic diameter; LVEDV: end-diastolic volume; LVEF: left




























b p<0.05 vs. active acromegalic patients.
esults
linical,  laboratory,  therapeutic  and
wo-dimensional  echocardiographic  data
ignificant  differences  were  demonstrated  in  most  echocar-
iographic  parameters  between  all  acromegalic  patients  and
ealthy  control  subjects.  Differences  between  active  and
nactive  acromegalic  patients  and  controls  are  presented  in
able  1.  IGF-1  levels  and  indices  and  early  transmitral  flow
elocity  differed  significantly  between  active  and  inactive
cromegalic  subjects  (Table  1).
hree-dimensional  speckle-tracking
chocardiography-derived  mitral  annular
arameters
ignificantly  increased  MA  dimensions  were  demonstrated  in





25etween  patients  with  acromegaly  and  age-  and  gender-
atched  controls.  No  differences  in  MA  data  were  seen
ccording  to  the  activity  of  acromegaly  (Table  2).
orrelations
o  significant  correlations  were  detected  between  MA
arameters  and  different  hormone  levels.
eproducibility measurements
he  differences  (mean  ±  standard  deviation)  measured
y  two  observers  for  end-diastolic  MAD,  MAA  and  MAP
ere  0.01±0.18  cm,  -0.04±0.79  cm2 and  --0.19±0.98
m,  respectively,  with  correlation  coefficients  between
hese  independent  measurements  of  0.97  (p<0.0001),
.96  (p<0.0001)  and  0.97  (p<0.0001),  respectively  (inter-
bserver  variability)  at  rest.  The  corresponding  values
6
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Table  2  Comparison  of  three-dimensional  speckle-tracking  echocardiography-derived  mitral  annular  morphological  and  func-
tional parameters  between  patients  with  acromegaly  and  controls.






MA  morphological  parameters
MAD-D,  cm  2.44  ±  0.34  2.81  ±  0.36a 2.86  ±  0.41a 2.76  ±  0.32a
MAA-D,  cm2  7.38  ±  1.93  9.67  ±  2.33a 10.12  ±  2.58a 9.22  ±  2.05a
MAP-D,  cm  10.27  ±  1.33  11.76  ±  1.42a 11.96  ±  1.59a 11.56  ±  1.27a
MAD-S,  cm  1.65  ±  0.37  2.00  ±  0.32a 2.08  ±  0.31a 1.91  ±  0.31a
MAA-S,  cm2  3.74  ±  1.19  5.14  ±  1.62a 5.43  ±  1.45a 4.85  ±  1.79a
MAP-S,  cm 7.36  ±  1.10 8.61  ±  1.23a 8.87  ±  1.10a 8.35  ±  1.34a
MA  functional  parameters
MAFAC,  % 48.3  ±  16.1 46.4  ±  11.3 45.3  ±  11.3 47.6  ±  11.7
MAFS, %  32.7  ±  13.9  28.6  ±  9.4  26.3  ±  11.3  30.9  ±  6.7
MA: mitral annular; MAA-D: end-diastolic mitral annular area; MAA-S: end-systolic mitral annular area; MAD-D: end-diastolic mitral







































































mitral annular perimeter; MAFAC: mitral annular fractional area c
a p<0.05 vs. controls.
or  intraobserver  variability  including  values  obtained  by
wo  measurements  by  observer  1  were  -0.03±0.19  cm,
.03±1.04  cm2 and  -0.01±0.95  cm,  respectively,  with
orrelation  coefficients  between  these  independent  mea-
urements  of  0.98  (p<0.0001),  0.96  (p<0.0001)  and  0.96
p<0.0001),  respectively.
The  corresponding  values  for  end-systolic  MAD,  MAA  and
AP  were  0.03±0.21  cm,  -0.03±0.39  cm2 and  0.03±0.43
m,  with  correlation  coefficients  of  0.97  (p<0.0001),  0.98
p<0.0001)  and  0.98  (p<0.0001),  respectively  (interobserver
ariability).  The  corresponding  parameters  for  intraob-
erver  variability  including  two  measurements  by  observer
 were  -0.02±0.21  cm,  -0.01±0.34  cm2 and  0.03±0.53
m,  respectively,  with  correlation  coefficients  between
hese  independent  measurements  of  0.98  (p<0.0001),  0.98
p<0.0001)  and  0.97  (p<0.0001),  respectively.
iscussion
n  the  early  stages  of  acromegaly,  excess  hGH  and  IGF-1
nduce  a  hyperkinetic  syndrome.  Subsequently  concentric
ypertrophy  develops,  together  with  LV  diastolic  dysfunc-
ion  and  eventually  impaired  systolic  function,  ending  in
eart  failure  unless  the  excess  hGH/IGF-1  is  treated.3
ypertension,  arrhythmias,  atherosclerosis,  coronary  artery
isease  and  heart  valve  disease  are  also  frequent  findings  in
cromegaly.3
Acromegaly  has  been  found  to  be  associated  with  an
ncreased  prevalence  of  regurgitant  valvular  heart  disease,
hich  is  dependent  on  the  duration  of  exposure  to  increased
GH  concentrations.11 Aortic  valve  regurgitation  (≥trace
everity)  was  present  in  30%  of  acromegalic  patients,  and
itral  regurgitation  (≥moderate  severity)  was  present  in
%  of  individuals  with  acromegaly.11 The  overall  prevalence
f  valve  abnormalities  is  higher  in  both  active  and  cured
cromegalic  patients.  The  persistence  of  valve  disease  in
atients  with  cured  acromegaly  is  likely  to  correlate  with
he  persistence  of  LV  hypertrophy.12
Under  normal,  healthy  conditions,  the  contractile  func-





25e; MAFS: mitral annular fractional shortening.
nd  ventricle  adjacent  to  the  mitral  annulus  results  in  a
phincter-like  motion  of  the  annulus,  which  is  an  innervated
brous  ring.  This  sphincter-like  narrowing  follows  the  car-
iac  cycle.13 The  circumferential  fibers  in  the  basal  segment
f  the  left  atrium  are  positioned  so  that  their  contraction
reates  a  centripetal  force  on  the  inner  segment  of  the  adja-
ent  fibrous  MA  ring,  leading  to  an  inward  motion  during  late
iastole.  The  superficial  oblique  fibers  of  the  LV  inlet  gen-
rate  a  torsional  force  on  the  outer  segment  of  the  mitral
nnulus,  causing  it  to  move  inwards  in  systole.13 Myocar-
ial  contraction  of  the  left  atrium  and  ventricle  following
he  cardiac  cycle  and  occurring  at  the  appropriate  time  are
equired  for  proper  contraction  of  the  mitral  annulus.13,14
In  the  present  study,  MA  dilation  with  preserved  func-
ion  was  demonstrated  in  acromegalic  patients  with  no
ignificant  mitral  regurgitation  and  with  no  relationship  to
he  disease’s  activity.  In  3D-STE  studies  for  deeper  insights
nto  acromegaly-associated  abnormalities,  impaired  LV  rota-
ional  mechanics  has  been  found,  with  reduced  apical  LV
otation  and  LV  twist  and  20%  incidence  of  absence  of  LV
wist  (LV  rigid  body  rotation)  in  acromegalic  patients.15
oreover,  increased  LV  radial  strains  have  been  demon-
trated,  together  with  changes  in  LA  functional  parameters,
uggesting  compensatory  increases  in  LV  and  LA  contractil-
ty  to  maintain  LV  pumping  function.16--18 These  results  could
xplain  both  the  MA  dilation  and  its  normal  function,  help-
ng  to  elucidate  these  particular  features  of  acromegalic
ardiomyopathy.
These  results  highlight  the  need  for  reliable  non-
nvasive  assessment  of  MA  dimensions  in  clinical  practice.
lthough  true  MA  diameter  is  underestimated  by  routine  2D
chocardiography,6 transthoracic  real-time  3D  echocardio-
raphy  (RT3DE)  had  been  validated  by  magnetic  resonance
maging  for  the  assessment  of  MA  dimensions  and  offers
uperior  accuracy  to  2D  echocardiography,  but  its  main
imitation  is  that  it  measures  the  2D-projected  annulus,  not
6--8ts  real  3D-shape. Transesophageal  RT3DE  (RT-3DE)  using
pecial  software  is  able  to  create  a  virtual  3D  model  of  the
itral  valve  and  its  annulus,  but  due  to  its  semi-invasive
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ptimal  for  simultaneous  assessment  of  strain,  rotational
nd  volumetric  parameters  of  the  heart  chambers  using  the
ame  acquired  3D  echocardiographic  dataset,  transthoracic
D-STE  has  a  similar  ability  to  transesophageal  RT-3DE  to
isualize  the  annulus.  It  is  easy  to  use,  the  learning  curve  is
hort,  there  is  no  radiation,  its  cost  is  relatively  low,  and  it
an  be  used  in  asymptomatic  non-cardiac  patients  such  as
ndividuals  with  acromegaly.20
tudy  limitations
n  our  patients,  acromegalic  cardiomyopathy  was  present  in
oth  early  and  later  stages,  which  could  affect  the  results.
D-STE  is  a  new  methodology  with  limited  spatial  (due  to
he  limited  number  of  piezoelectric  crystals)  and  tempo-
al  resolution  (mean  25±5  frames  per  second),  which  could
ffect  image  resolution  and  quality.  With  the  presented  3D-
TE-derived  MA  analysis,  the  3D  saddle  shape  of  the  annulus
annot  be  analyzed,  only  its  2D  projection,  which  could
heoretically  affect  the  measurements.  The  present  study
id  not  aim  to  assess  and  compare  3D-STE-derived  LV,  left
r  right  atrial  volumetric  and  strain  parameters  between
cromegalic  patients  and  matched  controls.
onclusions
A  dilation  was  seen  in  acromegaly  regardless  of  its  activity.
cromegaly  is  not  associated  with  MA  functional  impair-
ent.
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